Benzene exposure and its effects on brain inflammation and blood sugar control
Benzene exposure promotes neuroinflammation and metabolic dysregulation
['FUNDING_R01'] · WAYNE STATE UNIVERSITY · NIH-11260207
This project explores whether everyday benzene exposure causes brain inflammation that can lead to insulin resistance and worse blood sugar control in people at risk for type 2 diabetes.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WAYNE STATE UNIVERSITY (nih funded) |
| Locations | 1 site (DETROIT, UNITED STATES) |
| Trial ID | NIH-11260207 on ClinicalTrials.gov |
What this research studies
Researchers review existing human exposure data and combine that with laboratory experiments to learn how low-dose benzene affects metabolism and the brain. In animals they mimic common environmental exposure levels and measure blood sugar, insulin resistance, and signs of inflammation in the hypothalamus. The team focuses on glial cells (microglia and astrocytes) to see how brain inflammation may drive whole-body metabolic changes. Findings will be used to link real-world exposure data with biological mechanisms that could explain increased diabetes risk.
Who could benefit from this research
Good fit: People with or at high risk for adult-onset (type 2) diabetes—especially those with known environmental or occupational benzene exposure—would be most relevant to this research.
Not a fit: People with type 1 diabetes or metabolic problems clearly unrelated to environmental toxin exposure are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could point to reducing benzene exposure or targeting neuroinflammation as ways to lower the risk of insulin resistance and type 2 diabetes.
How similar studies have performed: Animal studies and a preliminary meta-analysis of human exposure data suggest links between benzene and metabolic problems, but translating those findings to human prevention or treatment remains largely untested.
Where this research is happening
DETROIT, UNITED STATES
- WAYNE STATE UNIVERSITY — DETROIT, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SADAGURSKI, MARIANNA — WAYNE STATE UNIVERSITY
- Study coordinator: SADAGURSKI, MARIANNA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult-Onset Diabetes Mellitus